Home
Conditions
EGFR Gene Mutation

Clinical trial condition

EGFR Gene Mutation

Explore clinical trials studying EGFR Gene Mutation. Study availability and eligibility vary by location and protocol.

41 public trials 14 recruiting studies

Refine in advanced search Browse all conditions

EGFR Gene Mutation trial results

Completed

Efficacy of Targeted Therapy Combined Chemotherapy in Advanced EGFR Positive NSCLC Patients

NCT04552613

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: China, Zhejiang Hangzhou, Zhejiang, China

View Trial Details

Completed

Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung Cancer

NCT02947386

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Neoadjuvant Afatinib Therapy for Potentially Resectable Stage III EGFR Mutation-Positive Lung Adenocarcinoma

NCT04201756

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +9 more
Locations: Shanghai Pulmonary Hospital Shang'ai, Shanghai Municipality, China

View Trial Details

Completed

Afatinib in Lung Cancer With EGFR Mutation From Circulating Tumor DNA

NCT02629523

Conditions: EGFR Gene Mutation, Lung Diseases, Lung Neoplasms, +5 more
Locations: Chonnam National University Hwasun Hospital Hwasun, Jeollanam-do, South Korea

View Trial Details

Completed

The Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients With Advanced EGFR Mutation-positive Non-small Cell Lung Cancer Treated With Afatinib

NCT04640870

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Not specified

View Trial Details

Completed

Frequency of EGFR and KRAS Mutations and Clinical-prognostic Correlation in Brazilian Lung Cancer Patients

NCT03171636

Conditions: EGFR Gene Mutation, KRAS Gene Mutation, Lung Diseases, +6 more
Locations: Hospital Erasto Gaertner Curitiba, Paraná, Brazil

View Trial Details

Active, Not Recruiting

Neoadjuvant Almonertinib Followed by Chemo-immunotherapy in II-IIIB EGFR-mutant NSCLC

NCT06300424

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

NCT03909334

Conditions: Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +15 more
Locations: Georgetown University Washington D.C., District of Columbia, United States

Moffitt Cancer Center Tampa, Florida, United States

Northwestern University Feinberg School of Medicine Chicago, Illinois, United States

Rush University Medical Center Chicago, Illinois, United States

View Trial Details

Active, Not Recruiting

Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung Cancer

NCT04013542

Conditions: ALK Gene Rearrangement, Bronchial Neoplasms, Carcinoma, Bronchogenic, +19 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Real-Time Monitoring of Symptoms in Lung Cancer Patients Receiving Oral Targeted Therapies

NCT05370469

Conditions: ALK Gene Mutation, BRAF, EGFR, +13 more
Locations: University of Virginia Charlottesville, Virginia, United States

View Trial Details

EGFR Gene Mutation

EGFR Gene Mutation trial results

Related conditions